Day: June 2, 2021

TORONTO, June 02, 2021 (GLOBE NEWSWIRE) — Adex Mining Inc. (“Adex” or the “Company”) (TSX‐V: ADE) announces today that the board of directors of the Company has appointed Volodymyr Ivanov as Interim Chief Financial Officer. Mr. Ivanov has over 9 years of corporate accounting and public accounting firm experience in various positions. He is a member of the Certified Public Accountants of Canada and the Association of Chartered Certified Accountants of the United Kingdom. He assumes the role from Olga Balanovskaya, who had served as Chief Financial Officer of the Company since October 2017. The Chief Financial Officer change is effective as of June 1, 2021. The Company wishes to thank Ms. Balanovskaya for her service. ABOUT ADEX Adex Mining Inc. is a Canadian junior mining company with an experienced management...

Global business jets are the backbone of the U.S. Air Force Battlefield Airborne Communications Node (BACN) program, and a go-to platform for special missions around the world BACN aircraft, known in the U.S. Air Force as the E-11A, are developed and modified by Bombardier’s highly skilled engineering teams in Wichita, Kansas Contract, which includes one firm aircraft order, underscores Bombardier’s status as a key U.S. aerospace employerWICHITA, Kansas, June 02, 2021 (GLOBE NEWSWIRE) — Bombardier is pleased to confirm an agreement between its Learjet Inc. subsidiary and the U.S. Air Force in support of the Battlefield Airborne Communications Node (BACN) program. The Indefinite Delivery Indefinite Quantity (IDIQ) contract provides the USAF with flexible ordering and includes an immediate firm order for one Global 6000 aircraft,...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, June 02, 2021 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (“Allied”) (TSX:AP.UN) announced today that it has filed and obtained receipts for a final base shelf prospectus. The final base shelf prospectus dated June 2, 2021 was filed with the securities regulatory authorities in each of the provinces of Canada. The final base shelf prospectus is valid for a 25-month period, during which time Allied may offer and issue, from time to time, units and debt securities, or any combination thereof, having an aggregate offering price of up to $3.0 billion. The specific terms of any offering of securities will be contained in a shelf prospectus supplement filed at the time of such offering. Allied will no longer...

VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) — Liquid Media Group Ltd. (the “Company”, “Liquid Media” or “Liquid”) (Nasdaq: YVR) announced today that it has accepted the resignation of Daniel Cruz from his positions on the Board of Directors of Liquid and its affiliates. The Company wishes to thank Mr. Cruz for his years of dedicated services to the Company’s board, and will continue to work with Mr. Cruz on a consultancy basis going forward. Further to its press release of March 31, 2021, the Company also announces the expiry of its letter of intent with CurrencyWorks Inc. The Company will continue to evaluate and review the possible paths available to it to use blockchain technology and tokenisation (of which NFTs are an element) to provide a novel and durable element of entertainment financing and monetization,...

Initial safety data showed combination regimen at the recommended Phase 2 dose was well tolerated; treatment-related adverse events primarily Grade 1 or 2, with no treatment-related discontinuations ORIC-101 plasma concentrations provided excellent target coverage; no evidence of drug-drug interaction with nab-paclitaxel Translational data showed pharmacodynamic modulation of GR biomarkers and high rates of GR expression in tumor types of interest Antitumor activity demonstrated across multiple advanced solid tumors in heavily pretreated patients, including those previously treated with a taxane-based therapy Extended PFS observed in patients with late-line relapsed pancreatic cancer who had previously progressed on or after nab-paclitaxel Conference call and webcast today at 5:00 p.m. ET SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June...

First proof-of-concept in vivo data for RNA editing using endogenous ADAR enzymes in alpha-1 antitrypsin deficiency ADAR editing resulted in therapeutically meaningful restoration of circulating functional AAT protein Wave’s program in alpha-1 antitrypsin deficiency aims to correct the single base mutation in mRNA derived from the SERPINA1 Z allele, thereby addressing both lung and liver manifestations of the disease CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced the first proof-of-concept preclinical data for its ADAR (adenosine deaminases acting on RNA)-mediated RNA editing (“ADAR editing”) program in alpha-1 antitrypsin deficiency (AATD)....

BURLINGTON, Mass., June 02, 2021 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference. The virtual fireside chat is scheduled to begin at 3:50 p.m. ET on Tuesday, June 8, 2021. To access the live webcast and subsequent archived recording of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com. About Flexion TherapeuticsFlexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company’s...

New York, NY, June 02, 2021 (GLOBE NEWSWIRE) — Cascade Acquisition Corp. (NYSE: CAS) (the “Company”) today announced that it has received a notice (“Notice”) from the NYSE Regulation staff of the New York Stock Exchange (the “NYSE”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the “Form 10-Q”) in a timely fashion. The Notice advised the Company that it was not in compliance with the NYSE’s continued listing requirements under the timely filing criteria established in Section 1007 of the NYSE Company Guide. As reported by the Company in its Form 12b-25 filed with the Securities and Exchange Commission (the “SEC”) on May 17, 2021, the Company was unable to file its Form 10-Q within the prescribed time period without unreasonable effort or...